Enterococcus Faecalis

• USES: • For the temporary relief of symptoms including: • mucus congestion • stomach discomfort • fever • headache • cough • joint discomfort • occasional diarrhea • bladder discomfort These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.ICD-10: R05.9, R51.9

DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.

Recent PubMed references pinned to Enterococcus Faecalis as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Antibacterial potential of five phages in controlling Enterococcus faecalis and Enterococcus faecium.
  Virology journal · 2026 · Tuomala H, Nylund T, Mustonen M, et al.
  PMID 42231337DOI 10.1186/s12985-026-03147-9
• Development of a multiplex recombinase polymerase amplification combined with a DNA strip for the rapid detection of Enterococcus faecium, Enterococcus faecalis, and vancomycin resistance genes.
  PeerJ · 2026 · Thaweesub P, Lulitanond A, Chanawong A, et al.
  PMID 42222498DOI 10.7717/peerj.21314
• Performance of EUCAST disc diffusion and supplementary methods to detect reduced susceptibility to linezolid in enterococci- the NordicAST LRE-study.
  The Journal of antimicrobial chemotherapy · 2026 · Haldorsen BC, Augustinussen MH, Matuschek E, et al.
  PMID 42207601DOI 10.1093/jac/dkag174
• High-dose daptomycin for the treatment of invasive infections due to Enterococcus faecalis isolates with intermediate susceptibility.
  The Journal of antimicrobial chemotherapy · 2026 · Drake S, Leininger J, Bazan JA, et al.
  PMID 42169506DOI 10.1093/jac/dkag179
• Characterization of a novel cell wall-associated nucleotidase of Enterococcus faecalis that degrades extracellular c-di-AMP.
  PLoS pathogens · 2026 · Morales Rivera AG, Bala A, Casella LG, et al.
  PMID 42160400DOI 10.1371/journal.ppat.1014206
• Extracellular vesicles derived from Enterococcus faecalis: inflammatory activation does not require internalization.
  Cell communication and signaling : CCS · 2026 · Gancino Guevara MA, Kardani A, Schomisch A, et al.
  PMID 42152018DOI 10.1186/s12964-026-02926-9
• ClO₂-induced VBNC state in Enterococcus faecalis poses a health risk in drinking water systems.
  Journal of hazardous materials · 2026 · Zhang Z, Cheng S, Duan M, et al.
  PMID 42150499DOI 10.1016/j.jhazmat.2026.142416
• Uncovering Antibiotic Resistance Signatures in Endodontic Enterococcus faecalis.
  The journal of contemporary dental practice · 2026 · Boreak N, Faqehi W, Ageeli RE, et al.
  PMID 42145161DOI 10.5005/jp-journals-10024-3942

The 10 most recently updated of 45 ClinicalTrials.gov registrations naming Enterococcus Faecalis as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• Biological, Radiographic and Clinical Evaluation of Various Inter-Visit Root Canal Dressings in Retreatment Cases
  Recruiting · Phase 1 · Interventional · 60 enrolled · Ain Shams University
  NCT07641933updated 2026-06-12
• Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis
  Recruiting · Phase 3 · Interventional · 30 enrolled · University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)
  NCT06870409updated 2026-03-19
• The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial
  Not yet recruiting · Interventional · 1,986 enrolled · Rigshospitalet, Denmark
  NCT07442357updated 2026-03-02
• Antibacterial Activity of Calcium Hydroxide and Betamethasone in Apical Periodontitis
  Not yet recruiting · Observational · 45 enrolled · Duygu Degirmencioglu
  NCT07351682updated 2026-01-20
• From Commensalism to Pathogenicity: Exploring the Pathophysiology of Bacteremia to Better Understand Enterococcus Faecalis Infective Endocarditis
  Not yet recruiting · Interventional · 90 enrolled · University Hospital, Clermont-Ferrand
  NCT07313865updated 2026-01-09
• Treatment of Enterococcus Faecalis Bacterem
  Recruiting · Observational · 700 enrolled · University Hospital, Strasbourg, France
  NCT07299539updated 2025-12-23
• Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
  Recruiting · Observational · 510 enrolled · IRCCS Azienda Ospedaliero-Universitaria di Bologna
  NCT06833593updated 2025-12-03
• A Comparative Evaluation of the Degree of Pain and MMP-9 Expression Following Instrumentation of Necrotic Pulps With Apical Periodontitis in One or Two Visits
  Not yet recruiting · Interventional · 28 enrolled · Marwa Hisham Mohamed Salah Eldin
  NCT07101003updated 2025-08-03
• Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.
  Recruiting · Phase 4 · Interventional · 284 enrolled · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
  NCT06423898updated 2025-07-25
• Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
  Recruiting · Interventional · 442 enrolled · Hospital for Special Surgery, New York
  NCT03704766updated 2025-06-22

Frequently asked questions

What is Enterococcus Faecalis used for?

According to FDA labeling, Enterococcus Faecalis carries indications including: USES: • For the temporary relief of symptoms including: • mucus congestion • stomach discomfort • fever • headache • cough • joint discomfort • occasional diarrhea • bladder discomfort These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.